Published in Stroke on April 01, 2000
A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.17
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 1.39
Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28
Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence (2010) 1.26
Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res (2008) 1.16
Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper. Qual Health Care (2001) 1.16
Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med (2008) 1.01
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation. Neth Heart J (2012) 0.94
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis. BMC Public Health (2014) 0.90
Recent developments in neurology. BMJ (2002) 0.90
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87
A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin. Int Arch Med (2013) 0.86
Edoxaban: an update on the new oral direct factor Xa inhibitor. Drugs (2014) 0.86
Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. Clin Res Cardiol (2014) 0.86
An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes. J Am Heart Assoc (2013) 0.86
Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study. J Am Heart Assoc (2014) 0.85
Gender differences in presenting signs and symptoms of acute ischemic stroke: a population-based study. Gend Med (2011) 0.82
Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians. Thromb J (2014) 0.82
Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany. Eur J Clin Pharmacol (2004) 0.81
Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation? Clin Interv Aging (2014) 0.81
Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation. Cardiovasc Ther (2015) 0.79
Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. Cardiol Ther (2013) 0.79
Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation? Cardiol Res Pract (2011) 0.79
Catheter ablation in combination with left atrial appendage closure for atrial fibrillation. J Vis Exp (2013) 0.79
Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes. Int Arch Med (2010) 0.78
Improving outpatient warfarin use for hospitalized patients with atrial fibrillation. Pharm Pract (Granada) (2008) 0.78
Why is warfarin underutilized in patients with atrial fibrillation? J Interv Card Electrophysiol (2004) 0.77
Treatment patterns associated with stroke prevention in patients with atrial fibrillation in three major cities in the People's Republic of china. Int J Gen Med (2013) 0.77
The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Ther Clin Risk Manag (2007) 0.76
Clinical and Economic Implications of AF Related Stroke. J Atr Fibrillation (2016) 0.75
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. J Am Geriatr Soc (2016) 0.75
Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation. Circ Cardiovasc Qual Outcomes (2017) 0.75
Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry. JAMA Intern Med (2015) 0.75
Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study. BMC Cardiovasc Disord (2016) 0.75
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future. Tex Heart Inst J (2016) 0.75
Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study. Cardiol Ther (2016) 0.75
A practical approach to the management of patients with atrial fibrillation. Heart Asia (2010) 0.75
Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score. J Am Coll Cardiol (2016) 0.75
Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation. Stroke (2000) 0.75
Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation. Healthcare (Basel) (2015) 0.75
A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals. BMJ Open (2014) 0.75
An integrated epidemiological and neural net model of the warfarin effect in managed care patients. Clin Pharmacol (2017) 0.75
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med (1992) 9.71
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med (1997) 5.93
Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43
Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA (2000) 5.31
Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med (2001) 5.29
Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect (1997) 4.62
Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA (1998) 4.38
Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med (1999) 4.30
Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc (1990) 3.67
Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA (1995) 3.56
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
A qualitative study of increasing beta-blocker use after myocardial infarction: Why do some hospitals succeed? JAMA (2001) 2.90
Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J (2000) 2.71
Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry (2001) 2.65
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med (1996) 2.28
Use of critical pathways to improve the care of patients with acute myocardial infarction. Am J Med (1999) 2.12
Data feedback efforts in quality improvement: lessons learned from US hospitals. Qual Saf Health Care (2004) 2.02
Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA (1997) 1.99
Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol (2001) 1.83
Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol (2000) 1.81
Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. Circulation (1995) 1.74
Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol (1995) 1.73
Major depressive disorder in coronary artery disease. Am J Cardiol (1987) 1.69
Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation (1999) 1.69
Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol (1995) 1.68
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med (1989) 1.65
Estrogenic pesticides: binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent territorial behaviour in male mice. Toxicol Lett (1995) 1.61
Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med (1998) 1.59
Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol (2001) 1.54
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J (2001) 1.50
Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med (2001) 1.48
Does dual chamber or atrial pacing prevent atrial fibrillation? The need for a randomized controlled trial. Pacing Clin Electrophysiol (1992) 1.45
Trends in the quality of care for Medicare beneficiaries admitted to the hospital with unstable angina. J Am Coll Cardiol (1998) 1.40
The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol (2001) 1.37
Thrombolytic therapy in older patients. J Am Coll Cardiol (2000) 1.34
Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation (1981) 1.34
Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol (1997) 1.33
Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations. Am J Med (2000) 1.30
Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med (2001) 1.29
Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke (2000) 1.27
Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol (2001) 1.26
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation (1995) 1.26
Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med (1995) 1.18
Early beta-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med (1999) 1.16
Carotid sinus hypersensitivity: beneficial effects of dual-chamber pacing. Am J Cardiol (1984) 1.15
Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med (1997) 1.14
The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res (1988) 1.13
Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project. Ann Intern Med (1995) 1.12
Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol (1987) 1.10
Cardiac operations in patients over 80 years of age. J Thorac Cardiovasc Surg (1985) 1.09
Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med (2000) 1.08
Performance of the '100 top hospitals': what does the report card report? Health Aff (Millwood) (1999) 1.07
Arrhythmias associated with sinus node dysfunction. Pathogenesis, recognition, and management. JAMA (1983) 1.06
Admission to hospitals with on-site cardiac catheterization facilities :impact on long-term costs and outcomes. Circulation (1998) 1.06
Sex differences in cardiac catheterization: the role of physician gender. JAMA (2001) 1.05
Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J (1999) 1.01
Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol (1986) 1.00
Hypokalemia as a cause of cardiac arrest: results of electrophysiologic testing and long-term follow-up. Am Heart J (1985) 1.00
Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J (1999) 0.99
Can practice guidelines be transported effectively to different settings? Results from a multicenter interventional study. Jt Comm J Qual Improv (2001) 0.98
Uric acid: is it a risk factor for cardiovascular disease? Am J Cardiol (2000) 0.97
Critical care by emergency physicians in American and English hospitals. Arch Emerg Med (1993) 0.97
Twenty most frequent DRG groups among Medicare inpatients age 65 or older in Connecticut hospitals, fiscal years 1991, 1992, and 1993. Conn Med (1995) 0.97
Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol (1994) 0.95
Nest defense and survival of offspring in highly aggressive wild Canadian female house mice. Physiol Behav (1995) 0.95
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation (2000) 0.94
Major depression in coronary artery disease patients with vs. without a prior history of depression. Psychosom Med (1992) 0.94
Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med (1993) 0.94
Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project. Am Heart J (2000) 0.94
Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy. Qual Life Res (2000) 0.93
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant (2004) 0.93
Clinical correlates of in-hospital costs for acute myocardial infarction in patients 65 years of age and older. Am Heart J (1998) 0.92
Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. Am Heart J (1987) 0.91
Quality of care among elderly patients hospitalized with unstable angina. Am Heart J (2001) 0.90
How do observational studies expand the evidence base for therapy? JAMA (2001) 0.90
Predictors of costs of caring for elderly patients discharged with heart failure. Am Heart J (2001) 0.90
Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med (1998) 0.89
Heart failure disease management programs: efficacy and limitations. Am J Med (2001) 0.89
Amyloid heart disease manifested by systemic arterial thromboemboli. Chest (1992) 0.89
Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J (1999) 0.88
Probability of appendicitis before and after observation. Ann Emerg Med (1991) 0.85
Cardiac conduction abnormalities and atrial arrhythmias associated with salicylate toxicity. Pharmacotherapy (1986) 0.84
Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm (2000) 0.84
Stability of index of heart rate variability in patients with congestive heart failure. Am Heart J (1995) 0.84
Validation of a clinical prediction rule for left ventricular ejection fraction after myocardial infarction in patients > or = 65 years old. Am J Cardiol (1997) 0.83
Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular Enlargement. J Am Coll Cardiol (1999) 0.83
Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. J Am Coll Cardiol (1988) 0.83